Search clinical trials for: First-in-Man

Total 7 results

Tau Pnu Medical Co., Ltd.

Recruiting

First-in-Man Early Feasibility Study for Transcatheter HOCM Septal Ablation

Hypertrophic Obstructive Cardiomyopathy

Korea, Republic of
Instituto Nacional de Cardiologia Ignacio Chavez
GSE Biomedical; Medstent SA de CV.

Withdrawn

First-in-Man Study: Safety and Efficacy of INC-1 Bare Metal Stent in the Novo Coronary Lesions.

Coronary Artery Disease | Stents | Treatment Outcome | Coronary Angiography | Angioplasty, Balloon, Coronary | Angioplasty | Humans

Mexico
EMD Serono
Merck KGaA, Darmstadt, Germany

Completed

First-in-Man, Dose-escalation Trial of C-met Kinase Inhibitor MSC2156119J in Subjects With Advanced Solid Tumors

Patients With Solid Tumors, Either Refractory to Standard Therapy or for Which no Effective Standard Therapy is Available

United States
Omeicos Therapeutics GmbH

Completed

Safety and Pharmacokinetic Study of OMT-28 in Healthy Subjects

Healthy Volunteers

Germany
Novo Nordisk A/S

Completed

First-in-Man Trial of NNC114-0005 in Healthy Subjects and Subjects With Rheumatoid Arthritis

Inflammation | Healthy | Rheumatoid Arthritis

Germany
Lepu Medical Technology (Beijing) Co., Ltd.

Unknown

NeoVas Bioresorbable Coronary Scaffold First-in-Man Study

Coronary Artery Disease

China
EMD Serono

Terminated

First-in-Man, Dose-escalation Trial of c-Met Kinase Inhibitor EMD 1204831 in Subjects With Advanced Solid Tumors

Solid Tumors

United States

3

Subscribe